Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delgocitinib cream dose-ranging in chronic hand eczema
NCT03683719Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Nov 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of delgocitinib in chronic hand eczema (CHE), sponsored by LEO Pharma. Started Nov 2018; status: completed.
02
Drugs
delgocitinib
03
Conditions
chronic hand eczema (CHE)
Beyond the preview
Go deeper on NCT03683719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03683719.